Compare ATRC & AZTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATRC | AZTA |
|---|---|---|
| Founded | 2000 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.5B |
| IPO Year | 2005 | 1996 |
| Metric | ATRC | AZTA |
|---|---|---|
| Price | $41.47 | $33.28 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | ★ $51.17 | $40.60 |
| AVG Volume (30 Days) | ★ 895.1K | 654.3K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 74.74 | N/A |
| EPS | ★ 0.18 | N/A |
| Revenue | $201,630,000.00 | ★ $593,821,000.00 |
| Revenue This Year | $15.27 | $6.99 |
| Revenue Next Year | $12.21 | $5.98 |
| P/E Ratio | $231.06 | ★ N/A |
| Revenue Growth | ★ 15.40 | N/A |
| 52 Week Low | $25.36 | $15.93 |
| 52 Week High | $43.18 | $41.73 |
| Indicator | ATRC | AZTA |
|---|---|---|
| Relative Strength Index (RSI) | 70.87 | 73.43 |
| Support Level | $39.40 | $28.89 |
| Resistance Level | $42.36 | $38.21 |
| Average True Range (ATR) | 1.79 | 1.45 |
| MACD | 0.18 | 0.37 |
| Stochastic Oscillator | 93.70 | 94.78 |
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.